Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Logan

Showing results (451-460 of 516) with videos related to

Pageof 52
Sort By:
Transplantation and Cellular Therapy|April 10, 2021
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe StudyMatthew D Seftel, Pintip Chitphakdithai, John P Miller, et al.
Blood|June 12, 2010
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosisVikas Gupta, Martin S Tallman, Wensheng He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2014
Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysisJack W Hsu, John R Wingard, Brent R Logan, et al.
Bone Marrow Transplantation|December 18, 2007
Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant ResearchM R Bishop, B R Logan, S Gandham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?John T Horan, Brent R Logan, Manza-A Agovi-Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2015
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated DonorsJo-Anne H Young, Brent R Logan, Juan Wu, et al.
The Lancet. Haematology|July 30, 2022
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trialAmy E DeZern, Mary Eapen, Juan Wu, et al.
Blood|August 30, 2014
Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802Javier Bolaños-Meade, Brent R Logan, Amin M Alousi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromesBart L Scott, Marcelo C Pasquini, Brent R Logan, et al.
Haematologica|June 30, 2018
A phase II/III randomized, multicenter trial of prednisone/sirolimus <i>versus</i> prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-<i>versus</i>-host disease: BMT CTN 0801Paul A Carpenter, Brent R Logan, Stephanie J Lee, et al.
Pageof 52

Showing results (451-460 of 516) with videos related to

Sort By:
Pageof 52
Transplantation and Cellular Therapy|April 10, 2021
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe StudyMatthew D Seftel, Pintip Chitphakdithai, John P Miller, et al.
Blood|June 12, 2010
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosisVikas Gupta, Martin S Tallman, Wensheng He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2014
Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysisJack W Hsu, John R Wingard, Brent R Logan, et al.
Bone Marrow Transplantation|December 18, 2007
Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant ResearchM R Bishop, B R Logan, S Gandham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?John T Horan, Brent R Logan, Manza-A Agovi-Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2015
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated DonorsJo-Anne H Young, Brent R Logan, Juan Wu, et al.
The Lancet. Haematology|July 30, 2022
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trialAmy E DeZern, Mary Eapen, Juan Wu, et al.
Blood|August 30, 2014
Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802Javier Bolaños-Meade, Brent R Logan, Amin M Alousi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromesBart L Scott, Marcelo C Pasquini, Brent R Logan, et al.
Haematologica|June 30, 2018
A phase II/III randomized, multicenter trial of prednisone/sirolimus <i>versus</i> prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-<i>versus</i>-host disease: BMT CTN 0801Paul A Carpenter, Brent R Logan, Stephanie J Lee, et al.
Pageof 52